Heme oxygenases, intrinsic defense system, as a novel therapeutic target for atherosclerotic disorders
Heme oxygenases, intrinsic defense system, as a novel therapeutic target for atherosclerotic disorders
批准号:
14570682
负责人:
ISHIKAWA Kazunobu
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
血红素加氧酶(HO)是血红素降解所必需的酶,在各种病理生理条件下通过产生胆汁色素、一氧化碳(CO)和铁蛋白而显示出抗氧化和抗炎特性。最近的一些研究表明HO反应在心血管疾病中具有生物学效应。HO是一种可诱导的HO,H 0 -1是由氧化脂蛋白、细胞因子、血流动力学变化、血管紧张素II和一氧化氮(NO)等多种应激因素诱导产生的。在此期间,我们观察到,H 0 -1诱导似乎是对这些有害刺激的适应性反应。动脉壁H 0 -1诱导清除活性氧,导致单核细胞粘附和趋化性减弱。H 0 -1诱导还减少血浆和动脉壁中的脂质过氧化。H 0 -1的这些性质表明这种酶的抗动脉粥样硬化作用。我们还研究了内皮细胞H 0 -1表达和胆红素在动脉粥样硬化形成中的作用。HO-1似乎也在血管成形术后再狭窄中发挥重要作用,再狭窄是与动脉粥样硬化相关的主要临床问题。作为临床研究,我们观察了急性心肌梗死患者血清中生物吡啉水平的变化。人类HO-1遗传学支持这些实验结果。我们目前正在继续研究,这将解决目前各种心血管疾病的问题。
英文摘要
Heme oxygenase (HO), an enzyme essential for heme degradation, shows anti-oxidative and anti-inflammatory properties via the production of bile pigmehts, carbon monoxide (CO) and ferritin induction under various pathophysiological conditions. A number of recent studies have shown biological effects of HO reaction in cardiovascular disorders. An inducible form of HO, H0-1, is induced by a variety of stresses such as oxidized lipoproteins, cytokines, hemodynamic changes, angiotensin II and nitric oxide (NO) in vascular wall. In this grant period, we observed that H0-1 induction seems to function as an adaptive response against these injurious stimuli. H0-1 induction in artery wall scavenged reactive oxygen species, which leads to the attenuation of monocyte adhesion and chemotaxis. H0-1 induction also reduces lipid peroxidation in plasma and artery wall. These properties of H0-1 suggest anti-atherogenic roles of this enzyme. We also examined the roles of endothelial H0-1 expression and bilirubin in atherogenesis. HO-1 also seems to play a significant role in restenosis after angioplasty, which is a major clinical problem associated with atherosclerosis. As a clinical research, we investigated the changes of the levels of biopyrrins in the patients with acute myocardial infarction. human HO-1 genetics supports these experimental results. We are currently continuing the research, which will solve current problems in various cardiovascular disorders.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ishikawa K: "Heme oxygenase-1 against vascular insufficiency : Roles of atherosclerotic disorders"Current Pharmaceutical Design. 9. 2489-2497 (2003)
Ishikawa K:“血红素加氧酶-1 对抗血管功能不全:动脉粥样硬化性疾病的作用”当前的药物设计。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishikawa, K: "Heme oxygenase-1 against vascular insufficiency : Roles of atherosclerotic disorders."Current Pharmaceutical Design.. 9. 2489-2497 (2003)
Ishikawa, K:“血红素加氧酶-1 对抗血管功能不全:动脉粥样硬化性疾病的作用。”当前药物设计.. 9. 2489-2497 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishikawa K.: "Heme oxygenase-1 against vascular insufficiency : Roles of atherosclerotic disorders."Current Pharmaceutical Design. 9. 2489-2497 (2003)
Ishikawa K.:“血红素加氧酶-1 对抗血管功能不全:动脉粥样硬化性疾病的作用。”当前的药物设计。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishikawa, K: "Anti-atherogenic properties of heme oxygenase. In Heme oxygenase in Biology and Medicine"Kluwer Academic / Plenum Publishers, New York, USA. 8(293-301) (2002)
Ishikawa, K:“血红素加氧酶的抗动脉粥样硬化特性。在生物学和医学中的血红素加氧酶”Kluwer Academy / Plenum Publishers,纽约,美国。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishikawa, K: "Anti-atherogenic properties of heme oxygenase. In Heme oxygenase in Biology and Medicine"Eds ; Abraham NG, Kluwer Academic/Plenum Publishers, New York, USA. 8(293-301) (2002)
Ishikawa,K:“血红素加氧酶的抗动脉粥样硬化特性。在生物学和医学中的血红素加氧酶”编辑;
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
Study on clinical implication of sarcopenia in cardiovascular disorders
-
批准号:24590893
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2012
-
负责人:ISHIKAWA Kazunobu
-
依托单位:
ANALYSES OF ANTI-ATHEROGENIC PROPERTIES OF HEME OXYGENASE-1
-
批准号:12670683
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:ISHIKAWA Kazunobu
-
依托单位:
Mechanism of targeting and transport of mitochondrial precursor proteins to mitochondria
-
批准号:04670135
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1992
-
负责人:ISHIKAWA Kazunobu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
-
批准号:91957111
-
项目类别:重大研究计划
-
资助金额:80.0万元
-
批准年份:2019
-
负责人:李佩盈
-
依托单位:
高尿酸血症促进动脉粥样硬化机制探讨
-
批准号:81170251
-
项目类别:面上项目
-
资助金额:14.0万元
-
批准年份:2011
-
负责人:刘梅林
-
依托单位:
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
-
批准号:81070247
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:秦树存
-
依托单位:
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
-
批准号:81000086
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:江立生
-
依托单位:
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
-
批准号:30971216
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:陈文强
-
依托单位:
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
-
批准号:30871040
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:陈文强
-
依托单位: